Cigarette smoking, cadmium exposure, and zinc intake on obstructive lung disorder.
OBJECTIVE
This study examined whether zinc intake was associated with lower risk of smoking-induced obstructive lung disorder through interplay with cadmium, one of major toxicants in cigarette smoke.


METHODS
Data were obtained from a sample of 6,726 subjects aged 40+ from the Third National Health and Nutrition Examination Survey. The forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) were measured using spirometry. Gender-, ethnicity-, and age-specific equations were used to calculate the lower limit of normal (LLN) to define obstructive lung disorder as: observed FEV1/FVC ratio and FEV1 below respective LLN. Zinc intake was assessed by questionnaire. Logistic regression analysis was applied to investigate the associations of interest.


RESULTS
The analyses showed that an increased prevalence of obstructive lung disorder was observed among individuals with low zinc intake regardless of smoking status. The adjusted odds of lung disorder are approximately 1.9 times greater for subjects in the lowest zinc-intake tertile than those in the highest tertile (odds ratio = 1.89, 95% confidence interval = 1.22-2.93). The effect of smoking on lung function decreased considerably after adjusting for urinary cadmium. Protective association between the zinc-to-cadmium ratio (log-transformed) and respiratory risk suggests that zinc may play a role in smoking-associated lung disorder by modifying the influence of cadmium.


CONCLUSIONS
While zinc intake is associated with lower risk of obstructive lung disorder, the role of smoking cession and/or prevention are likely to be more important given their far greater effect on respiratory risk. Future research is warranted to explore the mechanisms by which zinc could modify smoking-associated lung disease.
Lin
Yu-Sheng
YS
Cardiovascular Center and Health Management Center, National Taiwan University Hospital Yun-Lin Branch, Dou-Liou City, Taiwan. jouweilin@yahoo.com
Caffrey
James L
JL
Chang
Man-Huei
MH
Dowling
Nicole
N
Lin
Jou-Wei
JW
D000328:Adult; D002104:Cadmium / Q000009:adverse effects* / Q000652:urine; D019587:Dietary Supplements; D005260:Female; D005541:Forced Expiratory Volume; D006306:Health Surveys; D006801:Humans; D016015:Logistic Models; D008173:Lung Diseases, Obstructive / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D015995:Prevalence; D018570:Risk Assessment; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects* / Q000453:epidemiology; D016540:Smoking Cessation; D011795:Surveys and Questionnaires; D014481:United States / Q000453:epidemiology; D014797:Vital Capacity; D015032:Zinc / Q000008:administration & dosage*
D002104:Cadmium; D015032:Zinc
Cell Mol Biol (Noisy-le-grand). 2000 Mar;46(2):393-405
10774928
Diabetes Care. 2003 Feb;26(2):468-70
12547882
Eur Respir Rev. 2009 Dec;18(114):213-21
20956146
Ann Epidemiol. 2009 Aug;19(8):592-6
19406663
Am J Clin Nutr. 1999 Feb;69(2):243-9
9989687
Environ Health Perspect. 2008 Sep;116(9):1226-30
18795167
Clin Chem. 1983 Mar;29(3):477-80
6825258
Am Rev Respir Dis. 1987 Nov;136(5):1285-98
3674589
Respir Med. 2003 Feb;97(2):115-22
12587960
Thorax. 2001 Sep;56(9):721-6
11514694
N Engl J Med. 2004 Jun 24;350(26):2645-53
15215480
Free Radic Res. 2006 Mar;40(3):241-50
16484040
Vital Health Stat 1. 1994 Jul;(32):1-407
7975354
Am J Epidemiol. 2001 Dec 15;154(12):1087-8
11744510
Mol Med. 2007 Jul-Aug;13(7-8):371-5
17622324
Bull Environ Contam Toxicol. 1988 Aug;41(2):195-200
3207901
Physiol Res. 1998;47(6):453-61
10453753
Thorax. 2004 Mar;59(3):194-8
14985551
Environ Health Perspect. 2002 Feb;110(2):151-5
11836143
Clin Chest Med. 2007 Sep;28(3):479-513, v
17720039
Eur Respir J. 2005 Nov;26(5):948-68
16264058
Ann Rheum Dis. 1999 Nov;58 Suppl 1:I20-6
10577969
Free Radic Biol Med. 2004 Oct 15;37(8):1182-90
15451058
Exp Gerontol. 2008 May;43(5):370-7
18054190
Am J Respir Crit Care Med. 2007 Apr 15;175(8):798-804
17255565
Carcinogenesis. 2002 Jun;23(6):907-22
12082012
MMWR Morb Mortal Wkly Rep. 2003 Sep 5;52(35):842-4
12966360
Environ Health Perspect. 2008 Jan;116(1):51-6
18197299
Environ Health Perspect. 2004 Jul;112(10):1099-103
15238284
Nutrition. 1995 Jan-Feb;11(1 Suppl):100-5
7749254
J Allergy Clin Immunol. 2003 Nov;112(5):819-27; quiz 828
14610463
Respir Res. 2008 May 29;9:47
18510721
Occup Environ Med. 1998 Feb;55(2):132-7
9614399
Am J Respir Crit Care Med. 1999 Jan;159(1):179-87
9872837
Arch Intern Med. 1998 Sep 28;158(17):1855-67
9759681
J Inflamm (Lond). 2009 Jun 12;6:19
19523218
Environ Res. 2008 Feb;106(2):284-6
18053980
Environ Res. 2004 Nov;96(3):353-9
15364604
Environ Res. 2004 Jun;95(2):143-50
15147919
J Toxicol Environ Health A. 2001 Jul 6;63(5):321-50
11471865
J Nutr. 2000 May;130(5S Suppl):1367S-73S
10801945